Literature DB >> 18710387

Entecavir as a first-line treatment for HBV reactivation following polychemotherapy for lymphoma.

Philippe Colson, Patrick Borentain, Diane Coso, Christian Chabannon, Catherine Tamalet, René Gérolami.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18710387     DOI： 10.1111/j.1365-2141.2008.07318.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  8 in total

Review 1.  Hepatitis B virus management to prevent reactivation after chemotherapy: a review.

Authors:  Jessica P Hwang; John M Vierling; Andrew D Zelenetz; Susan C Lackey; Rohit Loomba
Journal:  Support Care Cancer       Date:  2012-08-30       Impact factor: 3.603

2.  Factors associated with hepatic dysfunction in hepatitis B-positive patients with postgastrectomy adenocarcinoma.

Authors:  Jian Xu; Hong Zhu; Yaqin Zhao; Xin Wang; Yali Shen; Wu Wang; Feng Xu
Journal:  Oncol Lett       Date:  2012-06-08       Impact factor: 2.967

Review 3.  Prevention of hepatitis B virus reactivation in immunosuppressive therapy or chemotherapy.

Authors:  Waka Ohishi; Kazuaki Chayama
Journal:  Clin Exp Nephrol       Date:  2011-06-01       Impact factor: 2.801

Review 4.  Current trends in management of hepatitis B virus reactivation in the biologic therapy era.

Authors:  Claudio M Mastroianni; Miriam Lichtner; Rita Citton; Cosmo Del Borgo; Angela Rago; Helene Martini; Giuseppe Cimino; Vincenzo Vullo
Journal:  World J Gastroenterol       Date:  2011-09-14       Impact factor: 5.742

5.  Use of entecavir to prevent hepatitis B virus reactivation during cytotoxic chemotherapy for solid malignancy.

Authors:  Riki Okita; Mamoru Takahashi; Hiroyuki Narahara; Yuichi Sanada; Morihito Okada; Yoshiiku Kawakami; Kazuaki Chayama; Kiwamu Okita
Journal:  Clin J Gastroenterol       Date:  2009-02-21

6.  Management of hepatitis B virus reactivation in patients with hematological malignancies treated with chemotherapy.

Authors:  D Francisci; F Falcinelli; E Schiaroli; M Capponi; B Belfiori; L Flenghi; F Baldelli
Journal:  Infection       Date:  2009-11-10       Impact factor: 3.553

7.  Hepatitis B surface antigen seroconversion after HBV reactivation in non-Hodgkin's lymphoma.

Authors:  Wei-Ping Liu; Wen Zheng; Yu-Qin Song; Ling-Yan Ping; Gui-Qiang Wang; Jun Zhu
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

8.  Clinical Profile and Efficacy of Antivirals in Hepatitis B Virus Reactivation, in Patients With Cancer Receiving Chemotherapy.

Authors:  Manzoor A Wani; Jaswinder S Sodhi; Ghulam N Yatoo; Altaf Shah; Sajad Geelani; Showkat A Zargar; Ghulam M Gulzar; Mushtaq Khan; Sheikh A Aziz
Journal:  J Clin Exp Hepatol       Date:  2020-07-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.